| scholarly article | Q13442814 |
| P50 | author | Eva Brittebo | Q4987754 |
| Oskar M Karlsson | Q40148096 | ||
| P2093 | author name string | Erika Roman | |
| Nils Gunnar Lindquist | |||
| P2860 | cites work | Biomagnification of cycad neurotoxins in flying foxes: implications for ALS-PDC in Guam | Q28201026 |
| Diverse taxa of cyanobacteria produce β-N-methylamino-l-alanine, a neurotoxic amino acid | Q28243477 | ||
| BMAA selectively injures motor neurons via AMPA/kainate receptor activation | Q28245144 | ||
| Beta-N-methylamino-L-alanine enhances neurotoxicity through multiple mechanisms | Q28273525 | ||
| Occurrence of beta-methylamino-l-alanine (BMAA) in ALS/PDC patients from Guam | Q28280946 | ||
| Beta-N-methylamino-L-alanine (BMAA) in novel South African cyanobacterial isolates | Q28283061 | ||
| Developmental and regional expression in the rat brain and functional properties of four NMDA receptors | Q28570615 | ||
| Global warming and cyanobacterial harmful algal blooms | Q31154652 | ||
| Retention of Microcystis aeruginosa and microcystin by salad lettuce (Lactuca sativa) after spray irrigation with water containing cyanobacteria | Q33867534 | ||
| Return of the cycad hypothesis - does the amyotrophic lateral sclerosis/parkinsonism dementia complex (ALS/PDC) of Guam have new implications for global health? | Q33988530 | ||
| The ALS/PDC syndrome of Guam and the cycad hypothesis | Q34779755 | ||
| Glutamate and anxiety | Q35729382 | ||
| Cyanobacterial toxins: risk management for health protection | Q36057610 | ||
| Evaluation of cognitive function in weanling rats: a review of methods suitable for chemical screening | Q36369059 | ||
| Brain regions and genes affecting postural control | Q36707951 | ||
| Neurotransmitters and the development of neuronal circuits | Q37082717 | ||
| Ethologically-based animal models of anxiety disorders | Q37924758 | ||
| Nutrient and other environmental controls of harmful cyanobacterial blooms along the freshwater-marine continuum | Q39102540 | ||
| Comparative aspects of the brain growth spurt | Q39707940 | ||
| Role of hippocampal signaling pathways in long-term memory formation of a nonassociative learning task in the rat | Q40416447 | ||
| A review of the validity and variability of the elevated plus-maze as an animal model of anxiety | Q41052733 | ||
| Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin | Q41458956 | ||
| Use of neurite outgrowth as an in vitro method of assessing neurotoxicity | Q41552612 | ||
| Production of the neurotoxin BMAA by a marine cyanobacterium | Q41917017 | ||
| Glycine site of the excitatory amino acid N-methyl-D-aspartate receptor in neonatal and adult brain | Q41981482 | ||
| Specific antagonism of behavioral action of "uncommon" amino acids linked to motor-system diseases | Q42209296 | ||
| Effects of novelty and habituation on acetylcholine, GABA, and glutamate release from the frontal cortex and hippocampus of freely moving rats | Q42510356 | ||
| Acetylcholine, theta-rhythm and activity of hippocampal neurons in the rabbit--IV. Sensory stimulation | Q42512278 | ||
| Age-specific N-methyl-D-aspartate-induced seizures: perspectives for the West syndrome model. | Q42612211 | ||
| Behavioral profile of wild mice in the elevated plus-maze test for anxiety | Q42644507 | ||
| Facilitated transport of the neurotoxin, beta-N-methylamino-L-alanine, across the blood-brain barrier | Q43613590 | ||
| Neonatal exposure to polybrominated diphenyl ether (PBDE 153) disrupts spontaneous behaviour, impairs learning and memory, and decreases hippocampal cholinergic receptors in adult mice | Q44612642 | ||
| Retention of the cyanobacterial neurotoxin beta-N-methylamino-l-alanine in melanin and neuromelanin-containing cells--a possible link between Parkinson-dementia complex and pigmentary retinopathy | Q46156727 | ||
| Lack of beta-methylamino-l-alanine in brain from controls, AD, or Chamorros with PDC. | Q46699325 | ||
| Co-occurrence of beta-N-methylamino-L-alanine, a neurotoxic amino acid with other cyanobacterial toxins in British waterbodies, 1990-2004. | Q46780634 | ||
| The role of the amygdala and olfaction in unconditioned fear in developing rats. | Q46884580 | ||
| Effect of local infusion of glutamate analogues into the nucleus accumbens of rats: an electrochemical and behavioural study | Q48139280 | ||
| The multivariate concentric square field test reveals different behavioural profiles in male AA and ANA rats with regard to risk taking and environmental reactivity | Q48389330 | ||
| Functional evaluation of cerebral microembolization in the rat. | Q48406084 | ||
| Lack of behavioral and neuropathological effects of dietary beta-methylamino-L-alanine (BMAA) in mice | Q48483322 | ||
| Neurochemical and neurobehavioral effects of neonatal administration of beta-N-methylamino-L-alanine and 3,3'-iminodipropionitrile | Q48490669 | ||
| N-methyl-D-aspartate (NMDA)-induced seizures in developing rats | Q48526625 | ||
| Influence of early beta-endorphin treatment on the behavior and reaction to beta-endorphin in the adult male rat. | Q48582268 | ||
| Interaction between beta-N-methylamino-L-alanine and excitatory amino acid receptors in brain slices and neuronal cultures. | Q48669893 | ||
| Thigmotaxis as a test for anxiolytic activity in rats. | Q51183679 | ||
| Effect of antemortem and postmortem factors on [3H]glutamate binding in the human brain | Q57781211 | ||
| P433 | issue | 2 | |
| P921 | main subject | Cyanobacteria | Q93315 |
| P304 | page(s) | 286-295 | |
| P577 | publication date | 2009-03-25 | |
| P1433 | published in | Toxicological Sciences | Q2446966 |
| P1476 | title | Selective brain uptake and behavioral effects of the cyanobacterial toxin BMAA (beta-N-methylamino-L-alanine) following neonatal administration to rodents | |
| P478 | volume | 109 |
| Q47891276 | A Single Neonatal Exposure to BMAA in a Rat Model Produces Neuropathology Consistent with Neurodegenerative Diseases |
| Q38734183 | A critical review of the postulated role of the non-essential amino acid, β-N-methylamino-L-alanine, in neurodegenerative disease in humans |
| Q36271885 | Acute β-N-Methylamino-L-alanine Toxicity in a Mouse Model. |
| Q60050817 | Angiopoietin-1 and ανβ3 integrin peptide promote the therapeutic effects of L-serine in an amyotrophic lateral sclerosis/Parkinsonism dementia complex model |
| Q34020244 | Beyond Guam: the cyanobacteria/BMAA hypothesis of the cause of ALS and other neurodegenerative diseases |
| Q39353704 | Cyanobacterial Neurotoxins: Their Occurrence and Mechanisms of Toxicity |
| Q39097793 | Cyanotoxins: producing organisms, occurrence, toxicity, mechanism of action and human health toxicological risk evaluation |
| Q41789221 | Environmental neurotoxin interaction with proteins: Dose-dependent increase of free and protein-associated BMAA (β-N-methylamino-L-alanine) in neonatal rat brain |
| Q33918172 | High resolution metabolite imaging in the hippocampus following neonatal exposure to the environmental toxin BMAA using ToF-SIMS |
| Q100962275 | Hippocampal neural stem cells are more susceptible to the neurotoxin BMAA than primary neurons: effects on apoptosis, cellular differentiation, neurite outgrowth, and DNA methylation |
| Q39033781 | Imaging mass spectrometry in drug development and toxicology |
| Q28239546 | Intracellular fibril formation, calcification, and enrichment of chaperones, cytoskeletal, and intermediate filament proteins in the adult hippocampus CA1 following neonatal exposure to the nonprotein amino acid BMAA |
| Q47146454 | Investigating β-N-Methylamino-l-alanine Misincorporation in Human Cell Cultures: A Comparative Study with Known Amino Acid Analogues |
| Q39263310 | L-BMAA induced ER stress and enhanced caspase 12 cleavage in human neuroblastoma SH-SY5Y cells at low nonexcitotoxic concentrations |
| Q28255645 | Long-term cognitive impairments in adult rats treated neonatally with beta-N-Methylamino-L-Alanine |
| Q36221110 | MALDI imaging delineates hippocampal glycosphingolipid changes associated with neurotoxin induced proteopathy following neonatal BMAA exposure. |
| Q21559548 | Maternal transfer of the cyanobacterial neurotoxin β-N-methylamino-L-alanine (BMAA) via milk to suckling offspring |
| Q92825461 | Mitotically heritable effects of BMAA on striatal neural stem cell proliferation and differentiation |
| Q30460930 | Neonatal exposure to the cyanobacterial toxin BMAA induces changes in protein expression and neurodegeneration in adult hippocampus |
| Q50495346 | Neurotoxicity of the Cyanotoxin BMAA Through Axonal Degeneration and Intercellular Spreading. |
| Q38960608 | Overview of the potent cyanobacterial neurotoxin β-methylamino-L-alanine (BMAA) and its analytical determination. |
| Q47648858 | Perinatal Exposure to the Cyanotoxin β-N-Méthylamino-L-Alanine (BMAA) Results in Long-Lasting Behavioral Changes in Offspring-Potential Involvement of DNA Damage and Oxidative Stress. |
| Q38616918 | Probing the lipid chemistry of neurotoxin-induced hippocampal lesions using multimodal imaging mass spectrometry |
| Q30444494 | Quality measures of imaging mass spectrometry aids in revealing long-term striatal protein changes induced by neonatal exposure to the cyanobacterial toxin β-N-methylamino-L-alanine (BMAA) |
| Q38753504 | Risk to human health associated with the environmental occurrence of cyanobacterial neurotoxic alkaloids anatoxins and saxitoxins. |
| Q28393837 | Searching for a link between the L-BMAA neurotoxin and amyotrophic lateral sclerosis: a study protocol of the French BMAALS programme |
| Q37519695 | Tau pathology involves protein phosphatase 2A in parkinsonism-dementia of Guam |
| Q52096422 | The Evaluation of BMAA Inhalation as a Potential Exposure Route Using a rat Model. |
| Q38544225 | The effects of the toxic cyanobacterium Limnothrix (strain AC0243) on Bufo marinus larvae |
| Q33927137 | Transfer of a cyanobacterial neurotoxin within a temperate aquatic ecosystem suggests pathways for human exposure |
| Q48194642 | Transport of BMAA into Neurons and Astrocytes by System xc. |
| Q47244005 | Β-N-Methylamino-L-Alanine (BMAA) Toxicity Is Gender and Exposure-Age Dependent in Rats |
| Q41874642 | β-N-Methylamino-L-alanine (BMAA) perturbs alanine, aspartate and glutamate metabolism pathways in human neuroblastoma cells as determined by metabolic profiling. |
Search more.